MX2024008710A - Inhibidores de factores del complemento y usos de los mismos. - Google Patents
Inhibidores de factores del complemento y usos de los mismos.Info
- Publication number
- MX2024008710A MX2024008710A MX2024008710A MX2024008710A MX2024008710A MX 2024008710 A MX2024008710 A MX 2024008710A MX 2024008710 A MX2024008710 A MX 2024008710A MX 2024008710 A MX2024008710 A MX 2024008710A MX 2024008710 A MX2024008710 A MX 2024008710A
- Authority
- MX
- Mexico
- Prior art keywords
- complement factor
- factor inhibitors
- disclosed
- disease
- compounds
- Prior art date
Links
- 230000000295 complement effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/027—Organoboranes and organoborohydrides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263299712P | 2022-01-14 | 2022-01-14 | |
| PCT/US2023/010783 WO2023137166A1 (en) | 2022-01-14 | 2023-01-13 | Inhibitors of complement factors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024008710A true MX2024008710A (es) | 2024-09-27 |
Family
ID=87279676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024008710A MX2024008710A (es) | 2022-01-14 | 2023-01-13 | Inhibidores de factores del complemento y usos de los mismos. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12522619B2 (https=) |
| EP (1) | EP4463462A4 (https=) |
| JP (1) | JP2025502254A (https=) |
| KR (1) | KR20240135818A (https=) |
| CN (1) | CN118715231A (https=) |
| AU (1) | AU2023207988A1 (https=) |
| CA (1) | CA3248405A1 (https=) |
| IL (1) | IL314164A (https=) |
| MX (1) | MX2024008710A (https=) |
| WO (1) | WO2023137166A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022020244A1 (en) | 2020-07-20 | 2022-01-27 | Annexon, Inc. | Inhibitors of complement factors and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965583A (en) | 1997-04-24 | 1999-10-12 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory disease |
| EP1971664B1 (en) | 2006-01-13 | 2015-09-09 | LG Chem, Ltd. | Emitting materials and organic light emitting device using the same |
| KR20100031723A (ko) * | 2007-07-07 | 2010-03-24 | 이데미쓰 고산 가부시키가이샤 | 크리센 유도체 및 이를 이용한 유기 전계 발광 소자 |
| KR101233377B1 (ko) * | 2008-12-30 | 2013-02-18 | 제일모직주식회사 | 신규한 유기광전소자용 화합물 및 이를 포함하는 유기광전소자 |
| WO2013049332A1 (en) * | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
| WO2015003146A1 (en) | 2013-07-03 | 2015-01-08 | Georgetown University | Boronic acid derivatives of resveratrol for activating deacetylase enzymes |
| DK3019240T3 (da) | 2013-07-09 | 2024-06-03 | Annexon Inc | Anti-komplementfaktor C1Q antistoffer og anvendelser deraf |
| TWI532741B (zh) * | 2013-09-04 | 2016-05-11 | 喜星素材股份有限公司 | 含吡唑之多環化合物及使用其之有機發光裝置 |
| KR101635154B1 (ko) | 2014-08-28 | 2016-06-30 | (주)더블유에스 | 피리딜기가 결합된 트리아진 유도체 및 이를 포함한 유기 전계발광 소자 |
| KR102233296B1 (ko) | 2014-11-18 | 2021-03-29 | 덕산네오룩스 주식회사 | 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치 |
| AR103397A1 (es) | 2015-01-13 | 2017-05-10 | Syngenta Participations Ag | Oxoborazoles microbicidas |
| US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| KR101981245B1 (ko) * | 2015-10-27 | 2019-05-22 | 주식회사 엘지화학 | 고리 화합물 및 이를 포함하는 유기 발광 소자 |
| KR101806464B1 (ko) | 2015-11-19 | 2017-12-07 | (주)랩토 | 피리딜기가 결합된 피리미딘 유도체 및 이를 이용한 유기 전계 발광 소자 |
| KR102496411B1 (ko) * | 2016-01-06 | 2023-02-06 | 덕산네오룩스 주식회사 | 유기전기 소자용 화합물, 이를 이용한 유기전기소자 및 그 전자 장치 |
| US10646488B2 (en) * | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| WO2019240471A1 (ko) | 2018-06-11 | 2019-12-19 | 주식회사 엘지화학 | 헤테로고리 화합물 및 이를 포함하는 유기 발광 소자 |
| WO2020032428A1 (ko) | 2018-08-09 | 2020-02-13 | 덕산네오룩스 주식회사 | 유기전기 소자용 화합물을 포함하는 유기전기소자 및 그 전자 장치 |
| CN109574917B (zh) | 2018-12-03 | 2020-12-08 | 武汉尚赛光电科技有限公司 | 一种芴酮衍生物及其制备和应用 |
| CN111087387B (zh) | 2019-12-26 | 2022-04-29 | 厦门天马微电子有限公司 | 一种有机化合物、显示面板及显示装置 |
| CN111423390A (zh) * | 2020-03-30 | 2020-07-17 | 北京燕化集联光电技术有限公司 | 一种新型结构化合物及其应用 |
| CN111662309B (zh) * | 2020-07-10 | 2021-11-09 | 北京燕化集联光电技术有限公司 | 一种多杂环结构化合物及其应用 |
| WO2022020244A1 (en) | 2020-07-20 | 2022-01-27 | Annexon, Inc. | Inhibitors of complement factors and uses thereof |
| CN113045585A (zh) * | 2021-03-16 | 2021-06-29 | 吉林奥来德光电材料股份有限公司 | 一种有机稠环化合物及其制备方法和应用 |
| CN113831332B (zh) * | 2021-10-29 | 2024-06-18 | 长春海谱润斯科技股份有限公司 | 一种含氮杂环衍生物及其在有机电致发光器件中的应用 |
-
2023
- 2023-01-13 IL IL314164A patent/IL314164A/en unknown
- 2023-01-13 CA CA3248405A patent/CA3248405A1/en active Pending
- 2023-01-13 CN CN202380022104.XA patent/CN118715231A/zh active Pending
- 2023-01-13 AU AU2023207988A patent/AU2023207988A1/en active Pending
- 2023-01-13 EP EP23740690.5A patent/EP4463462A4/en active Pending
- 2023-01-13 KR KR1020247027150A patent/KR20240135818A/ko active Pending
- 2023-01-13 JP JP2024541957A patent/JP2025502254A/ja active Pending
- 2023-01-13 WO PCT/US2023/010783 patent/WO2023137166A1/en not_active Ceased
- 2023-01-13 MX MX2024008710A patent/MX2024008710A/es unknown
- 2023-01-17 US US18/097,811 patent/US12522619B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL314164A (en) | 2024-09-01 |
| US12522619B2 (en) | 2026-01-13 |
| AU2023207988A1 (en) | 2024-07-11 |
| CA3248405A1 (en) | 2023-07-20 |
| EP4463462A4 (en) | 2025-06-25 |
| EP4463462A1 (en) | 2024-11-20 |
| KR20240135818A (ko) | 2024-09-12 |
| CN118715231A (zh) | 2024-09-27 |
| WO2023137166A1 (en) | 2023-07-20 |
| JP2025502254A (ja) | 2025-01-24 |
| US20230265109A1 (en) | 2023-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2023000683A2 (es) | Inhibidores de factores del complemento y usos de los mismos | |
| JOP20250246A1 (ar) | مثبطات kras | |
| JOP20230277A1 (ar) | مثبطات الكرومينون الألستيرية للفوسفونوسيتيد 3-كيناز (pi3k) لعلاج الأمراض | |
| CY1125784T1 (el) | Υποκατεστημενες δικυκλικες ετεροκυκλικες ενωσεις ως αναστολεις της prmt5 | |
| MX2022001421A (es) | Compuesto tetracíclico, método de preparación y uso del mismo. | |
| SA522432955B1 (ar) | Kras g12c مثبطات | |
| NI202100029A (es) | 2-amino-n-heteroaril-nicotinamidas como inhibidores de nav 1.8 | |
| CL2020002573A1 (es) | Inhibidores atf6 y sus usos. | |
| MX2022009309A (es) | Compuestos y usos de los mismos. | |
| CL2018002924A1 (es) | Inhibidores de bromodominios | |
| MX2021011606A (es) | Compuestos dirigidos a prmt5. | |
| CY1124510T1 (el) | Υποκατεστημενο βενζοφουρανιο, βενζοπυρρολιο, βενζοθειοφαινιο και δομικα σχετικοι αναστολεις του συμπληρωματος | |
| EA202191051A1 (ru) | Ингибитор аврора-киназы a для применения для лечения нейробластомы | |
| CY1125169T1 (el) | ΕΝΩΣΕΙΣ ΑΜΙΝΟΠΥΡΑΖΙΝΟ ΔΙΟΛΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΡΙ3Κ-γ | |
| MX2021004593A (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. | |
| MX376465B (es) | Compuestos de pirazolo[1,5-4]piridina sustituidos como inhibidores de la quinasa ret. | |
| EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
| CY1124814T1 (el) | Συμπυκνωμενα παραγωγα ιμιδαζολιου υποκατεστημενα με τριτοταγεις υδροξυ ομαδες ως αναστολεις ρi3κ-γαμμα | |
| EA202190395A1 (ru) | Замещенные гетероарилом сульфонамидные соединения и их применение в качестве терапевтических средств | |
| MX2021008984A (es) | Inhibidor jak y metodo de preparacion del mismo. | |
| EA201792214A1 (ru) | Соединения замещенного хиназолина | |
| AR117920A1 (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
| MX2021011986A (es) | Metodos de tratamiento de dolor neuropatico. | |
| JOP20240237A1 (ar) | مركبات أريل غير متجانسة لمعالجة الألم | |
| CY1124773T1 (el) | Τοπικη φαρμακευτικη συνθεση η οποια εμπεριεχει τουλαχιστον αμιτριπτυλινη για τη θεραπευτικη αντιμετωπιση του περιφερικου νευροπαθητικου αλγους |